| Financial Year |
March 31 2023 |
| Monetary Funds |
478,785,842.88 |
| Held-for-trading Financial Assets |
761,760,709.00 |
| Notes Receivable |
341,154,958.64 |
| Accounts Receivable |
957,678,546.84 |
| Advances to Suppliers |
49,868,487.52 |
| Other Receivables |
15,852,660.90 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
973,510,704.02 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
52,186,724.92 |
| Total Current Assets |
3,668,061,414.40 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
11,219,242.95 |
| Investment Properties |
25,777,338.17 |
| Fixed Assetes |
435,609,779.40 |
| Under-construction Projects |
76,193,023.11 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
105,723,322.74 |
| R&D expenses |
53,012,688.28 |
| Goodwill |
60,081,944.00 |
| Long-Term Deferred and Prepaid Expenses |
31,448,973.14 |
| Deferred Income Tax Assets |
29,639,490.88 |
| Other Non-Current Assets |
42,409,071.33 |
| Sub-Total of Non-Current Assets |
933,034,132.93 |
| Total Assets |
4,601,095,547.33 |
| Short-Term Loans |
393,105,109.94 |
| Trading Financial liabilities |
-- |
| Notes Payable |
83,986,205.64 |
| Accounts Payable |
359,894,855.15 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
57,446,302.22 |
| Taxes Payable |
26,785,925.78 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
1,739,385.59 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
148,431,613.23 |
| Other Current Liabilities |
34,959,019.55 |
| Sub-Total of Current Liabilities |
1,116,396,131.03 |
| Long-term Loans |
119,650,000.00 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
10,036,285.16 |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
7,120,244.98 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
175,104,591.94 |
| Total Liabilities |
1,291,500,722.97 |
| Paid-In Capital(Or Share Stock) |
413,796,402.00 |
| Capital Surplus |
1,632,307,975.38 |
| Surplus Reserve |
78,189,950.99 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
968,193,302.78 |
| Minority Stockholder's Interest |
217,112,531.48 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
3,092,482,292.88 |
| Owner's Equity（Stockholder's Equity） |
3,309,594,824.36 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
4,601,095,547.33 |
